digraph structs {
rankdir=LR;
g0 [shape=record,label="http://dikb.org/object-va\llue-specification/7a7a81a\ld-95f4-43b9-a84a-89ef6ec9\l1c36\lvalue specification\lobo:OBI_0001933\l|has specified value\lobo:OBI_0001937\l12\l",color=blue]
g0 -> g11 [label="\lobo:IAO_0000039\l"]
g1 [shape=record,label="http://dikb.org/data-rati\lo/84f26145-cf39-4fd6-9d00\l-f7a0f5064f28\lpharmacokinetic area unde\lr curve\lobo:DIDEO_00000046\l|label\lrdfs:label\lnefazodone-digoxin drug p\lackage auc Increase infor\lmation\l",color=blue]
g1 -> g69 [label="has specified value\lobo:OBI_0001937\l"]
g1 -> g10 [label="is_specified_output_of\lobo:OBI_0000312\l"]
g2 [shape=record,label="http://purl.obolibrary.or\lg/obo/IAO_0000136\l\lrdf:Property\l",color=blue]
g3 [shape=record,label="http://purl.obolibrary.or\lg/obo/IAO_0000039\l\lrdf:Property\l",color=blue]
g4 [shape=record,label="http://dikb.org/object-ma\lss/ca6d5f85-8eba-4e36-887\l4-4d03d599d6df\l\lobo:IAO_0000109\l",color=blue]
g5 [shape=record,label="http://purl.obolibrary.or\lg/obo/DIDEO_00000124\l\lrdfs:Class\l",color=blue]
g6 [shape=record,label="http://dikb.org/data-rati\lo/71946e97-152e-45ca-88fd\l-296b64545c13\ldrug maximum concentratio\ln measurement datum\lobo:DIDEO_00000038\l|label\lrdfs:label\ldivalproex sodium-INVEGA \ldrug package cmax Increas\le information\l",color=blue]
g6 -> g83 [label="has specified value\lobo:OBI_0001937\l"]
g6 -> g68 [label="is_specified_output_of\lobo:OBI_0000312\l"]
g7 [shape=record,label="http://dikb.org/data-rati\lo-type/3ba41382-b985-40ea\l-a885-859e72187f3c\lvalue specification\lobo:OBI_0001933\l|label\lrdfs:label\l50 Percent \l",color=blue]
g7 -> g53 [label="\lobo:OBI_0000051\l"]
g8 [shape=record,label="http://dikb.org/object-va\llue-specification/b8e4100\lb-d00d-499a-a024-b5b8fc90\lf9ac\lvalue specification\lobo:OBI_0001933\l|has specified value\lobo:OBI_0001937\l.2\l",color=blue]
g8 -> g73 [label="\lobo:IAO_0000039\l"]
g9 [shape=record,label="http://dikb.org/object-me\ltabolite/7afff739-dc80-4d\l7d-ac70-067ebef8749d\lmetabolite\lobo:CHEBI_25212\l",color=blue]
g9 -> g29 [label="inheres in\lobo:RO_0000052\l"]
g10 [shape=record,label="http://dikb.org/method/32\l2ec1eb-b9f3-4204-b2b3-204\la661257e9\l\lobo:DIDEO_00000124\l|label\lrdfs:label\lnefazodone-digoxin DDI cl\linical trial\l",color=blue]
g11 [shape=record,label="http://dikb.org/object-me\lasurement-unit-label/f61b\l3c3e-17f0-4a52-bc92-0cf80\lbcc8e99\l\lobo:IAO_0000003\l",color=blue]
g12 [shape=record,label="http://purl.obolibrary.or\lg/obo/OBI_0000051\l\lrdf:Property\l",color=blue]
g13 [shape=record,label="http://purl.obolibrary.or\lg/obo/IAO_0000003\l\lrdfs:Class\l",color=blue]
g14 [shape=record,label="http://purl.obolibrary.or\lg/obo/UO_0000187\l\lrdfs:Class\l",color=blue]
g15 [shape=record,label="http://purl.obolibrary.or\lg/obo/OBI_0000969\l\lrdfs:Class\l",color=blue]
g16 [shape=record,label="http://dikb.org/object-me\ltabolism/e63e7ddd-3107-43\l24-a73e-36346b6ee5f4\l\lobo:GO_000B152\l",color=blue]
g17 [shape=record,label="http://dikb.org/precipita\lnt-dose-specification/11f\l1621d-1eda-402d-a57d-4f29\l300f1624\ldose specification\lobo:OBI_0000969\l",color=blue]
g17 -> g49 [label="\lobo:IAO_0000136\l"]
g17 -> g35 [label="has value specification\lobo:OBI_0001938\l"]
g18 [shape=record,label="http://dikb.org/data-rati\lo-type-has-part/93073bf9-\l2221-4d19-acc1-6902b57cbc\lc9\lpercent\lobo:UO_0000187\l",color=blue]
g19 [shape=record,label="http://dikb.org/bearer-ob\lject/c6b6b1c0-35dd-49a3-9\l85f-54c34a9d1e1c\l",color=orange]
g19 -> g45 [label="\lobo:RO_0000051\l"]
g19 -> g27 [label="has part\lobo:BFO_0000051\l"]
g20 [shape=record,label="http://dikb.org/p-scatter\led-molecular-aggregate/e3\lccdeac-daf8-49e1-b076-420\l490555c58\lscattered molecular aggre\lgate\lobo:OBI_0000576\l",color=blue]
g20 -> g84 [label="\lobo:RO_0000051\l"]
g20 -> g30 [label="\lobo:RO_0002351\l"]
g20 -> g49 [label="\lobo:RO_0000051\l"]
g21 [shape=record,label="http://purl.obolibrary.or\lg/obo/RO_0002351\l\lrdf:Property\l",color=blue]
g22 [shape=record,label="http://purl.obolibrary.or\lg/obo/RO_0002353\l\lrdf:Property\l",color=blue]
g23 [shape=record,label="http://purl.obolibrary.or\lg/obo/RO_0002352\l\lrdf:Property\l",color=blue]
g24 [shape=record,label="http://dikb.org/data-rati\lo/d828ac42-2724-4c79-a6e4\l-7e1b7e767e2e\ldrug maximum concentratio\ln measurement datum\lobo:DIDEO_00000038\l|label\lrdfs:label\lnefazodone-digoxin drug p\lackage cmax Increase info\lrmation\l",color=blue]
g24 -> g10 [label="is_specified_output_of\lobo:OBI_0000312\l"]
g24 -> g28 [label="has specified value\lobo:OBI_0001937\l"]
g25 [shape=record,label="http://dikb.org/assertion\l/4478a225-fd6c-4a2c-848b-\lc7f1d3e811d1\ldrug-drug interaction des\lcription\lobo:DIDEO_00000001\l|label\lrdfs:label\lnefazodone-digoxin intera\lction description\l",color=blue]
g25 -> g1 [label="has part\lobo:BFO_0000051\l"]
g25 -> g48 [label="\lobo:IAO_0000136\l"]
g25 -> g76 [label="\lobo:IAO_0000136\l"]
g25 -> g24 [label="has part\lobo:BFO_0000051\l"]
g26 [shape=record,label="http://dikb.org/object-dr\lug/c8b4e404-f327-40c7-afd\l1-b0cc5f40ed0f\l\l\<obo:RxNorm_3407\>\l|label\lrdfs:label\ldigoxin\l",color=blue]
g26 -> g75 [label="\lobo:RO_0002352\l"]
g27 [shape=record,label="http://dikb.org/o-scatter\led-molecular-aggregate/de\ld3bbe8-7712-4f34-8c14-664\led37b79a5\lscattered molecular aggre\lgate\lobo:OBI_0000576\l",color=blue]
g27 -> g63 [label="has part\lobo:BFO_0000051\l"]
g27 -> g81 [label="\lobo:RO_0000051\l"]
g27 -> g70 [label="\lobo:RO_0000051\l"]
g28 [shape=record,label="http://dikb.org/data-rati\lo-type/cb840b93-7fa2-410c\l-9278-21d5ac83c64d\lvalue specification\lobo:OBI_0001933\l|has specified value\lobo:OBI_0001937\l29\l",color=blue]
g28 -> g40 [label="\lobo:OBI_0000051\l"]
g29 [shape=record,label="http://dikb.org/object-ch\lemical-substance/1afe1aa8\l-a7b8-4381-89b6-1116292a0\l2ca\lchemical substance\lobo:CHEBI_59999\l",color=blue]
g29 -> g75 [label="\lobo:RO_0002353\l"]
g30 [shape=record,label="http://dikb.org/precipita\lnt-drug/24f04095-2eea-47c\l0-9c46-91e73c7c8295\l\l\<obo:RxNorm_31565\>\l|label\lrdfs:label\lnefazodone\l",color=blue]
g31 [shape=record,label="http://purl.obolibrary.or\lg/obo/DRON_00000028\l\lrdfs:Class\l",color=blue]
g32 [shape=record,label="http://dikb.org/object-ch\lemical-substance/5ee660e2\l-34a3-478b-a310-9bff1ac36\l0c4\lchemical substance\lobo:CHEBI_59999\l",color=blue]
g32 -> g16 [label="\lobo:RO_0002353\l"]
g33 [shape=record,label="http://dikb.org/object-me\ltabolite/0093f44a-f71d-4c\l65-9598-7da27557ea4b\lmetabolite\lobo:CHEBI_25212\l",color=blue]
g33 -> g32 [label="inheres in\lobo:RO_0000052\l"]
g34 [shape=record,label="http://dikb.org/precipita\lnt-value-specification/44\lbc40b6-6c13-44c8-b166-156\l1c7d8c958\lvalue specification\lobo:OBI_0001933\l|has specified value\lobo:OBI_0001937\l1000\l",color=blue]
g34 -> g65 [label="\lobo:IAO_0000039\l"]
g35 [shape=record,label="http://dikb.org/precipita\lnt-value-specification/5e\l713c4a-5e31-46c5-b8ce-eb4\l505bca510\lvalue specification\lobo:OBI_0001933\l|has specified value\lobo:OBI_0001937\l200\l",color=blue]
g35 -> g67 [label="\lobo:IAO_0000039\l"]
g36 [shape=record,label="http://dikb.org/object-do\lse-specification/f10760d9\l-351f-4618-989b-0003396bf\l06a\ldose specification\lobo:OBI_0000969\l",color=blue]
g36 -> g8 [label="has value specification\lobo:OBI_0001938\l"]
g36 -> g4 [label="\lobo:IAO_0000136\l"]
g37 [shape=record,label="http://dikb.org/o-scatter\led-molecular-aggregate/fe\l841db3-1888-483b-b890-5ec\l48a48a2a4\lscattered molecular aggre\lgate\lobo:OBI_0000576\l",color=blue]
g37 -> g4 [label="\lobo:RO_0000051\l"]
g37 -> g26 [label="has part\lobo:BFO_0000051\l"]
g37 -> g57 [label="\lobo:RO_0000051\l"]
g38 [shape=record,label="http://purl.obolibrary.or\lg/obo/OBI_0000576\l\lrdfs:Class\l",color=blue]
g39 [shape=record,label="http://dikb.org/data-rati\lo-type-has-part/39aedc9d-\lfacf-489e-9031-8474fc4202\lb7\lpercent\lobo:UO_0000187\l",color=blue]
g40 [shape=record,label="http://dikb.org/data-rati\lo-type-has-part/f6a1e491-\l5e0d-4611-9586-f7c2f9f19d\lf2\lpercent\lobo:UO_0000187\l",color=blue]
g41 [shape=record,label="http://purl.obolibrary.or\lg/obo/BFO_0000051\l\lrdf:Property\l",color=blue]
g42 [shape=record,label="http://www.w3.org/1999/02\l/22-rdf-syntax-ns#type\l\lrdf:Property\l",color=blue]
g43 [shape=record,label="http://dikb.org/data-rati\lo/96a6242b-14fb-4c4e-8844\l-0db3c78beb5c\lpharmacokinetic area unde\lr curve\lobo:DIDEO_00000046\l|label\lrdfs:label\ldivalproex sodium-INVEGA \ldrug package auc Increase\l information\l",color=blue]
g43 -> g68 [label="is_specified_output_of\lobo:OBI_0000312\l"]
g43 -> g7 [label="has specified value\lobo:OBI_0001937\l"]
g44 [shape=record,label="http://purl.obolibrary.or\lg/obo/DIDEO_00000001\l\lrdfs:Class\l",color=blue]
g45 [shape=record,label="http://dikb.org/object-dr\lug-role/684362ad-dbad-49d\l2-ae10-3eb35b160d77\lprecipitant drug role\lobo:DIDEO_00000013\l",color=blue]
g46 [shape=record,label="http://purl.obolibrary.or\lg/obo/CHEBI_25212\l\lrdfs:Class\l",color=blue]
g47 [shape=record,label="http://purl.obolibrary.or\lg/obo/GO_000B152\l\lrdfs:Class\l",color=blue]
g48 [shape=record,label="http://dikb.org/bearer-ob\lject/0de1cf0a-6864-48f9-8\l9d6-88b20ad080e9\l",color=orange]
g48 -> g78 [label="\lobo:RO_0000051\l"]
g48 -> g37 [label="has part\lobo:BFO_0000051\l"]
g49 [shape=record,label="http://dikb.org/precipita\lnt-mass/4a4da6b9-37c2-41c\la-8db7-bdb69c1a57cc\l\lobo:PATO_0000125\l",color=blue]
g50 [shape=record,label="http://dikb.org/precipita\lnt-mass/6bcf94dc-82a5-403\ld-a860-a434babae476\l\lobo:PATO_0000125\l",color=blue]
g51 [shape=record,label="http://purl.obolibrary.or\lg/obo/OBI_0001937\l\lrdf:Property\l",color=blue]
g52 [shape=record,label="http://purl.obolibrary.or\lg/obo/OBI_0001933\l\lrdfs:Class\l",color=blue]
g53 [shape=record,label="http://dikb.org/data-rati\lo-type-has-part/a0a14e6a-\l2070-4ebe-ad26-26c4ae1f7a\le8\lpercent\lobo:UO_0000187\l",color=blue]
g54 [shape=record,label="http://dikb.org/precipita\lnt-drug-role/14692b0d-ab8\l2-4594-a0c3-134c7153acfa\lprecipitant drug role\lobo:DIDEO_00000013\l",color=blue]
g55 [shape=record,label="http://purl.obolibrary.or\lg/obo/OBI_0001938\l\lrdf:Property\l",color=blue]
g56 [shape=record,label="http://purl.obolibrary.or\lg/obo/DIDEO_00000013\l\lrdfs:Class\l",color=blue]
g57 [shape=record,label="http://dikb.org/object-ac\ltive-ingredient/93907f3e-\ld9f0-4014-bb61-6adfa6a401\la9\lactive ingredient\lobo:DRON_00000028\l",color=blue]
g58 [shape=record,label="http://dikb.org/bearer-pr\lecipitant/9b0e1eb0-803c-4\lc5c-a597-d842f916476a\l",color=orange]
g58 -> g85 [label="has part\lobo:BFO_0000051\l"]
g58 -> g54 [label="\lobo:RO_0000051\l"]
g59 [shape=record,label="http://purl.obolibrary.or\lg/obo/RO_0000051\l\lrdf:Property\l",color=blue]
g60 [shape=record,label="http://purl.obolibrary.or\lg/obo/RO_0000052\l\lrdf:Property\l",color=blue]
g61 [shape=record,label="http://purl.obolibrary.or\lg/obo/PATO_0000125\l\lrdfs:Class\l",color=blue]
g62 [shape=record,label="http://purl.obolibrary.or\lg/obo/CHEBI_59999\l\lrdfs:Class\l",color=blue]
g63 [shape=record,label="http://dikb.org/object-dr\lug/c871a45e-aa5c-44de-b89\lc-d15fc6e52451\l\l\<obo:RxNorm_686438\>\l|label\lrdfs:label\lINVEGA\l",color=blue]
g63 -> g16 [label="\lobo:RO_0002352\l"]
g64 [shape=record,label="http://purl.obolibrary.or\lg/obo/OBI_0000312\l\lrdf:Property\l",color=blue]
g65 [shape=record,label="http://dikb.org/precipita\lnt-measurement-unit-label\l/16bff675-506b-4357-a4b0-\lbb0384a993f1\l\lobo:IAO_0000003\l",color=blue]
g66 [shape=record,label="http://dikb.org/precipita\lnt-drug/77fa1a8c-9c6b-44a\l2-a90a-cf27930dea8b\l\l\<obo:MeSH_D014635\>\l|label\lrdfs:label\ldivalproex sodium\l",color=blue]
g67 [shape=record,label="http://dikb.org/precipita\lnt-measurement-unit-label\l/4dbbe60d-6c01-413b-8936-\l0ff66c0f2152\l\lobo:IAO_0000003\l",color=blue]
g68 [shape=record,label="http://dikb.org/method/ad\l3ad3ca-c2f7-4b77-8c21-772\l0d5dfbffb\l\lobo:DIDEO_00000124\l|label\lrdfs:label\ldivalproex sodium-INVEGA \lDDI clinical trial\l",color=blue]
g69 [shape=record,label="http://dikb.org/data-rati\lo-type/1fed5ed8-72b7-4d35\l-bc71-22b9d1a4c289\lvalue specification\lobo:OBI_0001933\l|has specified value\lobo:OBI_0001937\l15\l",color=blue]
g69 -> g39 [label="\lobo:OBI_0000051\l"]
g70 [shape=record,label="http://dikb.org/object-ma\lss/fe293fec-1e80-479c-976\lc-64c29203c47b\l\lobo:IAO_0000109\l",color=blue]
g71 [shape=record,label="http://dikb.org/precipita\lnt-active-ingredient/1129\lb05e-daaf-4e83-82e4-ae2b5\l690bef4\lactive ingredient\lobo:DRON_00000028\l",color=blue]
g72 [shape=record,label="http://dikb.org/object-do\lse-specification/b29c0ef9\l-671c-4d14-be23-72e72b8ad\lebd\ldose specification\lobo:OBI_0000969\l",color=blue]
g72 -> g70 [label="\lobo:IAO_0000136\l"]
g72 -> g0 [label="has value specification\lobo:OBI_0001938\l"]
g73 [shape=record,label="http://dikb.org/object-me\lasurement-unit-label/eea6\l0bb4-d006-4ecb-8be2-cf221\l3959755\l\lobo:IAO_0000003\l",color=blue]
g74 [shape=record,label="http://dikb.org/precipita\lnt-drug-role/7d3d4a99-63c\lc-4d3a-a6e8-f8fde1f733e2\lprecipitant drug role\lobo:DIDEO_00000013\l",color=blue]
g75 [shape=record,label="http://dikb.org/object-me\ltabolism/b123c329-636b-41\l34-8029-4481bde699df\l\lobo:GO_000B152\l",color=blue]
g76 [shape=record,label="http://dikb.org/bearer-pr\lecipitant/9c6b6dd7-cdb7-4\l978-a636-c93e3f93e1a9\l",color=orange]
g76 -> g74 [label="\lobo:RO_0000051\l"]
g76 -> g20 [label="has part\lobo:BFO_0000051\l"]
g77 [shape=record,label="http://www.w3.org/2000/01\l/rdf-schema#label\l\lrdf:Property\l",color=blue]
g78 [shape=record,label="http://dikb.org/object-dr\lug-role/46c7a53b-e30b-413\l7-a46e-3a371dcd1be1\lprecipitant drug role\lobo:DIDEO_00000013\l",color=blue]
g79 [shape=record,label="http://dikb.org/precipita\lnt-dose-specification/26f\lda64c-7e16-4414-9abf-9abd\laea5e4eb\ldose specification\lobo:OBI_0000969\l",color=blue]
g79 -> g50 [label="\lobo:IAO_0000136\l"]
g79 -> g34 [label="has value specification\lobo:OBI_0001938\l"]
g80 [shape=record,label="http://purl.obolibrary.or\lg/obo/IAO_0000109\l\lrdfs:Class\l",color=blue]
g81 [shape=record,label="http://dikb.org/object-ac\ltive-ingredient/fce5fc5b-\l77df-486a-a53d-853003d91c\l6b\lactive ingredient\lobo:DRON_00000028\l",color=blue]
g82 [shape=record,label="http://dikb.org/assertion\l/25585b06-629a-4de8-a710-\l9b05cb2e37be\ldrug-drug interaction des\lcription\lobo:DIDEO_00000001\l|label\lrdfs:label\ldivalproex sodium-INVEGA \linteraction description\l",color=blue]
g82 -> g19 [label="\lobo:IAO_0000136\l"]
g82 -> g43 [label="has part\lobo:BFO_0000051\l"]
g82 -> g58 [label="\lobo:IAO_0000136\l"]
g82 -> g6 [label="has part\lobo:BFO_0000051\l"]
g83 [shape=record,label="http://dikb.org/data-rati\lo-type/8280bf00-379f-4ea0\l-ac56-e8403f3e9eb9\lvalue specification\lobo:OBI_0001933\l|has specified value\lobo:OBI_0001937\l50\l",color=blue]
g83 -> g18 [label="\lobo:OBI_0000051\l"]
g84 [shape=record,label="http://dikb.org/precipita\lnt-active-ingredient/ed73\l1be5-ac13-40a3-bee1-39310\l4b90514\lactive ingredient\lobo:DRON_00000028\l",color=blue]
g85 [shape=record,label="http://dikb.org/p-scatter\led-molecular-aggregate/57\l38de7c-99c1-4000-af92-49e\lbabbcfa3e\lscattered molecular aggre\lgate\lobo:OBI_0000576\l",color=blue]
g85 -> g66 [label="\lobo:RO_0002351\l"]
g85 -> g50 [label="\lobo:RO_0000051\l"]
g85 -> g71 [label="\lobo:RO_0000051\l"]
}